Reduced Intensity Conditioning Transplant Using Haploidentical Donors
Status:
Completed
Trial end date:
2020-12-28
Target enrollment:
Participant gender:
Summary
This trial will evaluate the safety and efficacy of a reduced intensity allogeneic HSCT from
partially HLA-mismatched first-degree relatives utilizing PBSC as the stem cell source. The
primary objective of the study is to estimate the incidence of graft rejection and acute
GVHD. A secondary objective will be to estimate the incidence of the relapse, NRM, OS,
chronic GVHD and EFS.